project id: TCGA-READ; case submitter id: TCGA-DY-A1DC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; spectrophotometer method: UV Spec; age at index: 72; days to birth: -26436; days to death: 1258; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1928; year of death: 2003; age at diagnosis: 26436; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2000; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3946; days to sample procurement: 0; initial weight: 170.0; portion submitter id: TCGA-DY-A1DC-01A-31; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 75.0;